Levilimab

(Synonyms: BCD-089)
고객리뷰

Based on 1 Customer Validation

Levilimab (BCD-089) is an IL-6 receptor blocker that binds to both membrane-bound and soluble IL-6Rα. Levilimab inhibits IL-6 signaling, including classical signaling and trans-signaling, by blocking IL-6 binding. Levilimab can be used in research on rheumatoid arthritis and COVID-19.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • 보관:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocol
  • 순도&문서
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00